QL
FATE icon

Quarry LP’s Fate Therapeutics FATE Stock Holding History

Quarry LP’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$689 Buy
+255
New +$472 ﹤0.01% 2086
2024
Q2 		– Sell
-3,000
Closed -$22K – 1888
2024
Q1 		$22K Buy
+3,000
New +$18.6K ﹤0.01% 871

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Quarry LP's FATE Position: Q2 2026 in Review

Quarry LP opened a new position in Fate Therapeutics (FATE) in Q2 2026: 255 shares worth $689. The stake represents ﹤0.01% of the portfolio and ranks #2086 among its holdings. This is a return to the name: Quarry LP previously reported a position in FATE as recently as Q1 2024.

Quarry LP first reported a position in FATE in Q1 2024 and has held it in 2 quarters since. The position peaked at $22K in Q1 2024. 156 funds tracked by Wall St. Rank hold FATE as of Q2 2026.

  • Quarry LP held 255 shares of Fate Therapeutics worth $689 as of Q2 2026.
  • Fate Therapeutics was a new Quarry LP position in Q2 2026.
  • Fate Therapeutics made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #2086 holding.
  • Quarry LP first reported a position in Fate Therapeutics in Q1 2024 and has held it in 2 quarters since.
  • Quarry LP's Fate Therapeutics position peaked at $22K in Q1 2024.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.